Related Experiment Video

Updated: May 16, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Activation of systemic antitumor immunity via TRAIL-induced apoptosis

Britnie R James1, Thomas S Griffith

  • 1Microbiology, Immunology, and Cancer Biology Ph.D. Program; University of Minnesota; Minneapolis, MN USA.

Oncoimmunology
|November 22, 2012
PubMed

Insights

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can eliminate tumors and distant metastases. Combining TRAIL with CpG ODN generates a systemic antitumor immune response, enhancing cancer treatment efficacy.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapeutics

Background:

  • TNF-related apoptosis-inducing ligand (TRAIL) is investigated for selective tumoricidal activity.
  • Apoptotic tumor cells can potentially induce systemic antitumor immunity.
  • Localized administration strategies are being explored for cancer treatment.

Purpose of the Study:

  • To evaluate TRAIL's capacity to induce systemic antitumor immunity.
  • To investigate the role of apoptotic tumor cells in this immune response.
  • To assess the combination of TRAIL and CpG ODN for enhanced antitumor effects.

Main Methods:

  • Localized administration of TRAIL.
  • Combination therapy with CpG ODN.
  • Monitoring for systemic antitumor immune response and tumor elimination.

Main Results:

  • TRAIL administration, particularly with CpG ODN, can generate a systemic antitumor immune response.
  • This combination therapy demonstrated efficacy in eliminating primary tumors.
  • Distant metastases were also effectively targeted and eliminated.

Conclusions:

  • Localized TRAIL administration combined with CpG ODN effectively induces systemic antitumor immunity.
  • This therapeutic approach shows promise for eradicating both primary tumors and metastases.
  • TRAIL-based combination therapies represent a viable strategy for cancer treatment.

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...